Biblio

33557 resultats trouvés
R
Morin-Crini N, Lichtfouse E, Fourmentin M, Ribeiro ARita Lado, Noutsopoulos C, Mapelli F, Fenyvesi E, Vieira MGurgel Ade, Picos-Corrales LA, Moreno-Pirajan JCarlos et al..  2022.  Removal of emerging contaminants from wastewater using advanced treatments. A review. ENVIRONMENTAL CHEMISTRY LETTERS. 20:1333-1375.
Chevallier O, Zhou N, He J, Loffroy R, Wang YXiang J.  2018.  Removal of evidential motion-contaminated and poorly fitted image data improves IVIM diffusion MRI parameter scan-rescan reproducibility. ACTA RADIOLOGICA. 59:1157-1167.
Ibrahim C, Mehri I, Hammami S, Mejri S, Hassen A, Pothier P.  2017.  Removal of human astroviruses from hospital wastewater by two biological treatment methods: natural oxidizing lagoons and rotating biodisks. DESALINATION AND WATER TREATMENT. 89:287-296.
Zhang D, Crini G, Lichtfouse E, Rhimi B, Wang C.  2020.  Removal of Mercury Ions from Aqueous Solutions by Crosslinked Chitosan-based Adsorbents: A Mini Review. CHEMICAL RECORD. 20:1220-1234.
Romero D, Chlala D, Labaki M, Royer S, Bellat J-P, Bezverkhyy I, Giraudon J-M, Lamonier J-F.  2015.  Removal of Toluene over NaX Zeolite Exchanged with Cu2+. CATALYSTS. 5:1479-1497.
Bulle R, Chouly F, Hale JS, Lozinski A.  2020.  Removing the saturation assumption in Bank-Weiser error estimator analysis in dimension three. APPLIED MATHEMATICS LETTERS. 107:106429.
Boquet Y.  2017.  The renaissance of tramways and urban redevelopment in France. MISCELLANEA GEOGRAPHICA. 21:5-18.
Chopard R, Jimenez D, Serzian G, Ecarnot F, Falvo N, Kalbacher E, Bonnet B, Capellier G, Schiele F, Bertoletti L et al..  2021.  Renal dysfunction improves risk stratification and may call for a change in the management of intermediate- and high-risk acute pulmonary embolism: results from a multicenter cohort study with external validation. CRITICAL CARE. 25:57.
Anty R., Coilly A., Fougerou C., De Ledinghen V., Duvoux C., Di Martino V., Radenne S., Kamar N., Leroy V., Canva V. et al..  2016.  Renal Dysfunction in Liver Transplant Patients Treated with SOFOSBUVIR Based-Regimen for HCV Recurrence: Results from a Large French Prospective Multicentric ANRS CO23 CUPILT. TRANSPLANTATION. 100:S92.
Anty R., Coilly A., Fougerou C., De Ledinghen V., Houssel-Debry P., Duvoux C., Di Martino V., Radenne S., Kamar N., D'alteroche L. et al..  2016.  RENAL DYSFUNCTION IN LIVER TRANSPLANT PATIENTS TREATED WITH SOFOSBUVIR BASED-REGIMEN FOR HCV RECURRENCE: RESULTS FROM A LARGE FRENCH PROSPECTIVE MULTICENTRIC ANRS CO23 CUPILT. JOURNAL OF HEPATOLOGY. 64:S550.
Mitry E, Lombard-Bohas C, Caroll-Bosc F-X, Legoux J-L, Rusznlewski PB, Seitz JFrancois, Terrebonne E, Etienne P-L, Bougier P, Benmansour HBrixi et al..  2014.  Renal effects of streptozocin: Preliminary results of the STREPTOTOX prospective study.. JOURNAL OF CLINICAL ONCOLOGY. 32
Mitry E., Brixi H., Lecomte T., Lombard-Bohas C., Seitz J.F, Legoux J.L, Mahamat A., Ruszniewski P., Etienne P.L, Le Malicot K. et al..  2014.  Renal Effects of Streptozocin: Preliminary Results of the STREPTOTOX Study. NEUROENDOCRINOLOGY. 99:268.
Saliba F, Duvoux C, Dharancy S, Dumortier J, Calmus Y, Gugenheim J, Kamar N, Salame E, Cransac MNeau, Vanlemmens C et al..  2019.  RENAL, EFFICACY AND SAFETY OUTCOMES USING AN EVEROLIMUS (EVR)-BASED CALCINEURIN INHIBITOR (CNI)-FREE REGIMEN VS STANDARD TACROLIMUS (TAC) AFTER LIVER TRANSPLANT (LTX): THREE-YEAR FINDINGS FROM CERTITUDE. TRANSPLANT INTERNATIONAL. 32:220.
Saliba F., Duvoux C., Dharancy S., Dumortier J., Calmus Y., Gugenheim J., Kamar N., Salame E., Neau-Cransac M., Vanlemmens C. et al..  2020.  RENAL, EFFICACY AND SAFETY OUTCOMES USING AN EVEROLIMUS (EVR)-BASED CALCINEURIN INHIBITOR (CNI)-FREE REGIMEN VERSUS STANDARD TACROLIMUS (TAC) AFTER LIVER TRANSPLANT (LTX): FOUR-YEAR FINDINGS FROM CERTITUDE. TRANSPLANT INTERNATIONAL. 33:26.
Saliba F., Duvoux C., Dharancy S., Dumortier J., Calmus Y., Gugenheim J., Kamar N., Salame E., Neau-Cransac M., Vanlemmens C. et al..  2019.  RENAL, EFFICACY AND SAFETY OUTCOMES USING AN EVEROLIMUS (EVR)-BASED CALCINEURIN INHIBITOR (CNI)-FREE REGIMEN VS STANDARD TACROLIMUS (TAC) AFTER LIVER TRANSPLANT (LTX): THREE-YEAR FINDINGS FROM CERTITUDE. TRANSPLANT INTERNATIONAL. 32:18.
Saliba F., Duvoux C., Dharancy S., Dumortier J., Calmus Y., Gugenheim J., Kamar N., Salame E., Neau-Cransac M., Vanlemmens C. et al..  2018.  RENAL, EFFICACY AND SAFETY OUTCOMES USING AN EVEROLIMUS (EVR)-BASED CALCINEURIN INHIBITOR (CNI)-FREE REGIMEN VERSUS STANDARD TACROLIMUS (TAC) AFTER LIVER TRANSPLANT (LTX): TWO-YEAR FINDINGS FROM CERTITUDE. TRANSPLANT INTERNATIONAL. 31:15-16.
Saliba F, Duvoux C, Dharancy S, Dumortier J, Calmus Y, Gugenheim J, Kamar N, Salame E, Cransac MNeau, Vanlemmens C et al..  2019.  RENAL, EFFICACY AND SAFETY OUTCOMES USING AN EVEROLIMUS (EVR)-BASED CALCINEURIN INHIBITOR (CNI)-FREE REGIMEN VS STANDARD TACROLIMUS (TAC) AFTER LIVER TRANSPLANT (LTX): THREE-YEAR FINDINGS FROM CERTITUDE. TRANSPLANT INTERNATIONAL. 32:220.
Saliba F., Duvoux C., Dharancy S., Dumortier J., Calmus Y., Gugenheim J., Kamar N., Salame E., Neau-Cransac M., Vanlemmens C. et al..  2018.  RENAL, EFFICACY AND SAFETY OUTCOMES USING AN EVEROLIMUS (EVR)-BASED CALCINEURIN INHIBITOR (CNI)-FREE REGIMEN VERSUS STANDARD TACROLIMUS (TAC) AFTER LIVER TRANSPLANT (LTX): TWO-YEAR FINDINGS FROM CERTITUDE. TRANSPLANT INTERNATIONAL. 31:15-16.
Saliba F., Duvoux C., Dharancy S., Dumortier J., Calmus Y., Gugenheim J., Kamar N., Salame E., Neau-Cransac M., Vanlemmens C. et al..  2019.  RENAL, EFFICACY AND SAFETY OUTCOMES USING AN EVEROLIMUS (EVR)-BASED CALCINEURIN INHIBITOR (CNI)-FREE REGIMEN VS STANDARD TACROLIMUS (TAC) AFTER LIVER TRANSPLANT (LTX): THREE-YEAR FINDINGS FROM CERTITUDE. TRANSPLANT INTERNATIONAL. 32:18.
Saliba F., Duvoux C., Dharancy S., Dumortier J., Calmus Y., Gugenheim J., Kamar N., Salame E., Neau-Cransac M., Vanlemmens C. et al..  2020.  RENAL, EFFICACY AND SAFETY OUTCOMES USING AN EVEROLIMUS (EVR)-BASED CALCINEURIN INHIBITOR (CNI)-FREE REGIMEN VERSUS STANDARD TACROLIMUS (TAC) AFTER LIVER TRANSPLANT (LTX): FOUR-YEAR FINDINGS FROM CERTITUDE. TRANSPLANT INTERNATIONAL. 33:26.
Chopard R., Jimenez D., Serzian G., Ecarnot F., Falvo N., Kalbacher E., Bonnet B., Capellier G., Schiele F., Bertoletti L. et al..  2020.  Renal function improves mortality prediction in acute pulmonary embolism: results of a multicentre cohort study with external validation in the RIETE registry. EUROPEAN HEART JOURNAL. 41:2239.
Chopard R., Jimenez D., Serzian G., Ecarnot F., Falvo N., Kalbacher E., Bonnet B., Capellier G., Schiele F., Bertoletti L. et al..  2020.  Renal function improves mortality prediction in acute pulmonary embolism: results of a multicentre cohort study with external validation in the RIETE registry. EUROPEAN HEART JOURNAL. 41:2239.
Nezam D, Morel P, Faguer S, Karras A, Aniort J, Titeca-Beauport D, Solignac J, Ducloux D, Mesbah R, Carron P-L et al..  2019.  Renal Histopathological Classifications Predict the Renal Outcomes of Plasma Exchange-Treated ANCA-Associated Vasculitides with Renal Failure. ARTHRITIS & RHEUMATOLOGY. 71
Sudour-Bonnange H, Vanrenterghem A, Nobili F, Guigonis V, Boudailliez B.  2015.  Renal late effects in patients treated for cancer in childhood. BULLETIN DU CANCER. 102:627-635.
Juvet C, Siddeek B, Yzydorczyk C, Vergely C, Nardou K, Armengaud J-B, Benahmed M, Simeoni U, Cachat F, Chehade H.  2020.  Renal Programming by Transient Postnatal Overfeeding: The Role of Senescence Pathways. FRONTIERS IN PHYSIOLOGY. 11:511.

Pages